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Abstract
Local translation of dendritic mRNAs plays an important role in neuronal development and synaptic plasticity. Although
several hundred putative dendritic transcripts have been identified in the hippocampus, relatively few have been verified by
in situ hybridization and thus remain uncharacterized. One such transcript encodes the protein neuronatin. Neuronatin has
been shown to regulate calcium levels in non-neuronal cells such as pancreatic or embryonic stem cells, but its function in
mature neurons remains unclear. Here we report that neuronatin is translated in hippocampal dendrites in response to
blockade of action potentials and NMDA-receptor dependent synaptic transmission by TTX and APV. Our study also reveals
that neuronatin can adjust dendritic calcium levels by regulating intracellular calcium storage. We propose that neuronatin
may impact synaptic plasticity by modulating dendritic calcium levels during homeostatic plasticity, thereby potentially
regulating neuronal excitability, receptor trafficking, and calcium dependent signaling.
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Introduction
Local translation of mRNAs in neuronal dendrites provides a
means for rapidly eliciting site-specific changes in protein levels
during neuronal development and synaptic plasticity. Dendritic
localization of poly-A containing RNAs and translation machin-
ery, such as ribosomes and translation factors, enables protein
synthesis hundreds of microns from the soma [1,2,3,4]. Gene
expression profiling of isolated dendrites identified as many as 450
putative dendritic mRNAs in the hippocampus [5,6,7,8]. Howev-
er, only a handful of mRNAs, including Arc (activity regulated
cytoskeletal protein), Eef1a (eukaryotic elongation factor 1 a), and
CaMKIIa (Ca
2+/CaM dependent kinase IIa) have been verified as
being dendritically localized and/or translated in response to
stimuli, such as those that induce long-term potentiation (LTP),
long-term depression (LTD), or homeostatic plasticity [9,10,
11,12,13].
One uncharacterized dendritic mRNA encodes the protein
neuronatin (NNAT) which was first identified in embryonic rat
brain and subsequently shown to be enriched in isolated dendrites
[5,14]. NNAT is expressed in rat as two alternatively spliced
isoforms, encoding an 81 or 54 amino acid protein (NNATa or b)
[14]. Its levels are highest early in brain development, with the
NNATa isoform being expressed at E7–10 and the b isoform
appearing at E11–14, during the onset of neurogenesis. NNATa
and b levels continue to increase during neurogenesis (between
E16–19) and decrease postnatally [15]. The Nnat gene is also
maternally imprinted and contains a neuron-restrictive silencer
element [16,17]. Non-neuronal data from pancreatic beta and
3T3-L1 cells shows that NNAT resides in the endoplasmic
reticulum (ER) and modulates intracellular Ca
2+stores [18,19].
NNAT is strikingly similar to phospholamban (PLN), an ER-
resident Ca
2+ regulator found in cardiac muscle. Both proteins
bear a-helical membrane domains and highly basic cytoplasmic
tails [14]. However, even though the mechanism by which PLN
regulates Ca
2+ by SERCA pump inhibition has been studied
extensively, much less is known about the cellular and molecular
function of NNAT in mature neurons, particularly within the
dendrite [20].
Local intracellular Ca
2+ concentrations are tightly controlled and
compartmentalized in neurons [21]. Due to its potent effects,
cytoplasmic Ca
2+ is rapidly cleared by mechanisms such as
extrusion into the ER or mitochondrial uptake [22,23,24]. Aberrant
Ca
2+ levels may result in abnormal synaptic development and
learning-relatedplasticity,andmaycontribute tocognitivedisorders
such as Fragile X Syndrome [25,26,27,28,29]. Calcium signaling,
particularly in dendrites and spines, has been tied to LTP and LTD
induction, as well as spine morphology [22,26,30,31,32]. Local
translation of dendritically localized transcripts such as calmodulins,
CaMKIIa ´, visinin-like protein-1, NMDA (N-methyl-D-aspartic
acid), and AMPA (2-amino-3-(5-methyl-3-oxo-1,2- oxazol-4-yl)pro-
panoic acid) receptors may be a means for regulating dendritic Ca
2+
signaling [5,33,34,35,36,37]. Although uncharacterized in neurons,
NNAT may also belong to this group due to the dendritic
localization of its mRNA and its ability to regulate intracellular
Ca
2+ [18,19].
Since local translation and Ca
2+ regulation are critical during
synaptic plasticity, and given its ability to modulate intracellular
Ca
2+ in non-neuronal cells, we asked how NNAT translation was
locally regulated and if it might be involved in dendritic Ca
2+
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e24879signaling in mature hippocampal neurons. We also examined a
potential interaction between Nnat mRNA and FMRP (Fragile X
Mental Retardation Protein), an RNA binding protein that
regulates dendritic mRNA localization and translation, and whose
absence or loss-of-function is thought to underlie Fragile X
syndrome [38,39,40]. Here, we report that NNAT is indeed
dendritically translated in mature neurons during homeostatic
plasticity and that it likely regulates dendritic calcium by
modulation of intracellular Ca
2+ stores.
Results
Localization of neuronatin mRNA and protein in mature
hippocampal dendrites
To understand the function of NNAT in mature neurons, we
first examined NNAT expression in rat hippocampal tissue (P21).
At this age, neurons in the hippocampus have formed synaptic
connections and are capable of displaying forms of learning-
related and homeostatic plasticity [41,42]. In vivo, Nnat mRNA was
somatodendritically expressed, but its expression was restricted
primarily to hippocampal CA2 and CA3 regions (Fig. 1A). Our
data agrees with the Allen Mouse Brain Atlas (http://www.
brainatlas.org), which further shows expression in the caudate,
hypothalamus, and amygdala. Immunohistochemistry in rat
hippocampal slice also showed somatodendritic NNAT protein
expression in CA2 and CA3 as demonstrated by co-localization
with the somatodendritic marker MAP2 (microtubule-associated
protein 2) (Fig. 1B, Fig. S1A). NNAT intensity was strongest in
proximal dendrites. NNAT antibody specificity was verified by
immunostaining HeLa cells overexpressing NNAT (Fig. S1B).
Both NNAT isoforms were present in the P21 and adult
hippocampus as confirmed by Western blot and RT-PCR
(Fig. 1C and Fig. S1C).
We next used fluorescent in situ hybridization (FISH) combined
with immunocytochemistry (ICC) to examine the intracellular
localization of Nnat mRNA and protein in mature hippocampal
cultures. Both were observed in distal dendrites (.150 mm) as
demonstrated by co-localization of Nnat mRNA with MAP2
(Fig. 2A, Fig. S2A). NNAT puncta were also observed along the
length of the dendrite, but only partially co-localized with the
synaptic marker PSD-95, suggesting that NNAT expression is not
restricted to synapses (Fig. 2B and C). NNAT did not co-localize
with the axonal marker b III tubulin by immunofluorescence (data
not shown). NNAT mRNA and protein were observed in both
excitatory and inhibitory neurons as determined by cell morphol-
ogy [43].
To examine synaptic enrichment, we assessed levels of Nnata
and b mRNA and protein in synaptoneurosomes (SNS), a
biochemically enriched synaptic preparation [11,44,45]. Interest-
ingly, enrichment of both Nnata and b transcripts was not reflected
at the protein level, implying that translational control may play a
significant role in regulating synaptic NNAT expression (Fig. 2D).
PSD-95 (a synaptic marker) and histone 3 (a somatic marker)
protein levels were used to verify synaptoneurosome enrichment
relative to whole tissue (Fig. S2B).
Dendritic NNAT translation in response to TTX/APV
treatment
To determine whether Nnat might be locally translated, we first
examined if NNAT protein co-localized with dendritic translation
hot spots, characterized as discrete ribosome-containing sites along
the dendrite [46]. Co-immunofluorescent staining of NNAT and
ribosomes (using the Y10b antibody, which recognizes the 5.8S
ribosomal subunit) showed co-localization between dendritic
NNAT puncta and ribosomes in cultured hippocampal dendrites
(Fig. 3A and B) [47].
NMDA receptor blockade with APV ((2R)-amino-5-phospho-
novaleric acid) in the presence of TTX (tetrodotoxin), induces a
rapid, local protein synthesis dependent form of homeostatic
plasticity [41,48]. Since TTX/APV treatment increases synaptic
Ca
2+ permeability, we wanted to examine whether NNAT, with its
putative role in Ca
2+ regulation, might also be translated in
response to TTX/APV treatment [11,41,49,50]. We observed a
2.4-fold increase in total NNAT levels after 8 hrs of TTX/APV in
cultured hippocampal neurons (Fig. 3C and D). To determine if
this induction was transcription-dependent, neurons were pre-
treated with a transcriptional inhibitor, actinomycin D (ActD).
ActD pretreatment reduced TTX/APV-induced NNAT levels by
25%, implying a transcriptional component to the cell-wide
increase in NNAT (Fig. 3C and D). We also pretreated neurons
with a protein synthesis inhibitor, anisomycin, to ensure that
NNAT induction was translation-dependent. As expected, aniso-
mycin pretreatment completely abolished any increase in NNAT
protein levels (Fig. 3C and D).
To specifically determine whether the increase in NNAT
represents dendritic protein synthesis, we performed immunoflu-
orescent staining in cultured neurons using antibodies against
NNAT and MAP2 (Fig. 4A and B). Upon TTX/APV treatment,
we observed a 3.3-fold increase in dendritic signal. Importantly,
even in the presence of ActD, we continued to observe a 3-fold
increase in dendritic NNAT levels following TTX/APV. By
contrast, pretreatment with the translation inhibitor anisomycin
completely blocked this increase. Neither ActD nor anisomycin
alone had any effect on NNAT baseline levels (Fig. 4C). These
data indicate that an increase in translation, not transcription, is
responsible for the elevated dendritic NNAT levels in response to
TTX/APV treatment.
Since 8 hrs of TTX/APV treatment allows ample time for
proteins to be somatically synthesized then transported to distal
dendritic sites, we sought to further delineate the dendritic
contribution to the NNAT increase by using short inhibition of
NMDAR activity (with APV) following action potential blockade
as shown by Sutton et al. [41]. We treated neurons with TTX for
8 hrs, applied APV only during the last hour, and observed an
anisomycin-sensitive 2.2-fold increase in dendritic NNAT levels;
TTX alone had no effect (Fig. 4A–C). This effect persisted even
during transcriptional inhibition with ActD, supporting the notion
that NNAT is dendritically translated (Fig. 4A and C). Similar
effects were also observed using another translation inhibitor,
cycloheximide (Fig. S3).
During TTX/APV treatment, NMDAR-mediated Ca
2+ influx
is inhibited, suppressing EF2K (elongation factor 2 kinase) activity,
resulting in enhanced translation [51]. To see if TTX/APV-
induced NNAT translation could occur as a result of modulating
EF2 phosphorylation, we treated SNS with either NH125 (an
EF2K inhibitor) or 2 nM okadaic acid (OA), which inhibits EF2
dephosphorylation via protein phosphatase 2a [51,52,53]. SNS
provide the advantage of being rapidly obtainable from tissue and
are amenable to pharmacological manipulation and biochemical
analysis [54]. We first confirmed pharmacological control of EF2
phosphorylation and observed that levels of phospho-EF2
decreased in response to NH125 and increased as a result of
OA treatment (Fig. 5A). In response to NH125 treatment, we
observed a 1.3-fold increase in NNAT levels; no significant
increase was observed in response to okadaic acid (Fig. 5B).
Inhibition of translation with anisomycin attenuated the NH125-
induced increase in NNAT protein. Although stimuli other than
TTX/APV blockade may also influence EF2 phosphorylation, our
NNAT Is a Dendritically Translated Ca
+2 Regulator
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dependent manner.
Neuronatin overexpression increases baseline calcium
levels
NNAT overexpression in non-neuronal cell types modulates
intracellular Ca
2+ storage, resulting in elevated cytoplasmic Ca
2+
levels [18,19].To see if NNAT could regulate dendritic Ca
2+ levels,
we overexpressed NNATb, the predominant isoform, in mature
hippocampal cultures followed by loading with Calcium Crimson-
AM, a BAPTA-based Ca
2+ indicator dye [55,56]. NNATb was
overexpressed using a dual expression construct containing GFP
and the full length rat Nnatb mRNA sequence (including 59 and 39
UTRs to preserve translational control and localization) driven by
separate promoters (GFP/NNATb) (Fig. 6A). Neurons overex-
pressing NNATb (as identified by GFP fluorescence) exhibited a
1.3-fold increase in dendritic Ca
2+ levels compared to those
transfected with the empty vector (Fig. 6B). A brief five minute
glutamate application was used to verify that Ca
2+ had not
reached ceiling levels.
NNAT regulates calcium by antagonizing SERCA pump
activity
Given the structural similarities between NNAT and phospho-
lamban, and the presence of SERCA in neuronal dendrites and
synapses, we hypothesized that NNAT might function as a
SERCA pump regulator (Fig. S2B) [57]. ER localization of NNAT
has been previously observed in other cell types, but has not been
examined in mature neurons [18,58]. We verified NNAT
localization to neuronal ER by co-immunostaining NNAT with
Figure 1. Neuronatin is expressed in the P21 rat hippocampus. (A) Nnat in situ hybridization (ISH) in hippocampus visualized using alkaline
phosphatase. Nnat mRNA is present in hippocampal regions CA2 and 3. Arrowheads denote dendritic localization. Scale bar: 20 mm. Schematic of cell
body and dendritic layer boundary in 406 image is shown (bottom right panel). (B) NNAT immunofluorescent staining in the CA2 region of
hippocampus showing dendritic localization, NNAT (red), MAP2 (green). Scale bar: 20 mm. (C) left, Western blot for NNAT and right, RT-PCR for Nnat
mRNA using rat hippocampal tissue showing both a and b isoforms.
doi:10.1371/journal.pone.0024879.g001
NNAT Is a Dendritically Translated Ca
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localization, consistent with ER distribution (Fig. 6C). Microsomes
(an ER-enriched preparation) generated from rat hippocampi, also
showed a 1.8-fold enrichment of NNAT (Fig. 6D). Microsome
purity was verified by immunoblotting with the KDEL (which
recognizes Grp78 and Grp94) or SERCA2 antibody (Fig. 6D).
We next examined whether NNAT interacts with the SERCA
pump. Using an antibody against SERCA2, the predominant
neuronal isoform, we were able to co-immunoprecipitate (co-IP)
NNAT from hippocampal microsomes suggesting a possible
association (Fig. 7A and B). However, to show a more direct
association, we first crosslinked microsomes using DSP (dithiobis
[succinimidyl propionate]), followed by co-IP using the SERCA2
antibody. In uncrosslinked microsomes, we detected SERCA2 at
114 kD by Western blot (Fig. 7C, left). Upon crosslinking and co-
IP, however, we observed a size-shifted SERCA2-containing
complex at ,120–150 kD (Fig. 7C, left). Re-probing of the same
blot with the NNAT antibody revealed that this complex also
contained NNAT (Fig. 7C, right).
Given this association, we hypothesized that the elevation in
dendritic Ca
2+ following NNAT overexpression was due to
increased NNAT inhibition of SERCA pump activity. If this were
true, we would expect NNAT overexpression to occlude Ca
2+
induction by a SERCA inhibitor, such as thapsigargin. Indeed, no
additive Ca
2+ increase was observed following thapsigargin
treatment in neurons transfected with GFP/NNATa ˆ, while in
empty GFP vector transfected neurons, thapsigargin increased
dendritic Ca
2+ by 1.23-fold (Fig. 7D). Similar to before,
overexpression of GFP/NNATa ˆ resulted in a 1.25-fold increase
in dendritic Ca
2+. To exclude the possibility that NNATb
overexpression induced a Ca
2+ ceiling effect, following thapsigar-
gin, we treated GFP/NNATa ˆ transfected neurons with an
additional 5 min pulse of glutamate (to activate extracellular
Ca
2+ influx or intracellular Ca
2+ release) and observed a 1.54-fold
increase in Ca
2+ over the GFP/NNATb transfected baseline levels
(data not shown).
Fragile X Mental Retardation Protein binds Nnat mRNA
A screen for mRNAs associated with FMRP (Fragile X Mental
Retardation protein) by Miyashiro et al., suggested a putative
association between FMRP and Nnat mRNA [38]. Recent work
has also shown that the loss of FMRP impairs TTX/APV-induced
homeostatic plasticity [59]. Using hippocampal tissue, we
confirmed that Nnat mRNA associates with FMRP by RNA co-
Figure 2. NNAT mRNA and protein are present in dendrites and synapses. (A) NNAT protein (red) in cultured hippocampal neurons; Nnat
mRNA (green); somatodendritic marker, MAP2 (blue). Scale bar: 10 mm. Zoom of region boxed in white. Arrowheads denote sites of co-localization.
(B) NNAT puncta along the dendrite as shown by immunofluorescence, MAP2 (green), NNAT (red), and merge. Scale bar: 10 mm. (C) Right,
immunocytochemistry shows partial NNAT co-localization with synapses using antibodies against NNAT (red) and the synaptic marker PSD-95
(green), arrowheads in merge denote sites of co-localization. Scale bar: 10 mm. (D) NNATa and a ˆ mRNAs are enriched in synaptoneurosomes (SNS) as
analyzed by RT-PCR (25 cycles) using equal amounts of total or SNS RNA. (E) NNAT protein levels in total hippocampal (total) versus SNS as assessed
by immunoblot. Actin levels were used as a loading control.
doi:10.1371/journal.pone.0024879.g002
NNAT Is a Dendritically Translated Ca
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verified by enrichment of two known FMRP binding targets, Arc
and Fmr1 [10,60] and the lack of Gapdh enrichment in the
immunoprecipitated sample (Fig. 8A) [39,61]. Immunoprecipita-
tion of FMRP protein was specific as assessed by rabbit IgG and
no antibody negative controls (Fig. 8B). However, when
attempting to co-immunoprecipitate Nnat mRNA and FMRP
from hippocampal tissue at high stringency using ultraviolet
crosslinking (which is specific for protein-nucleic acid interactions)
and an SDS-containing wash buffer, we were unable to detect a
direct association between FMRP and Nnat mRNA [38,62]. This
lack of association by UV crosslinking suggests the intriguing
possibility that an unknown intermediate, such as a protein or
RNA species, may facilitate the interaction between FMRP and
Nnat mRNA.
Discussion
Although high embryonic and early postnatal expression has
suggested significant roles for NNAT during neuronal develop-
ment, its function in mature neurons has not been examined.
Here, we show that Nnat mRNA is expressed and dendritically
translated during homeostatic plasticity in mature hippocampal
neurons. Moreover, we have demonstrated that it regulates
dendritic Ca
2+ levels by antagonizing SERCA pump activity.
Given the importance of Ca
2+ signaling during neuronal events,
together with data that Nnat mRNA associates with FMRP, we
propose that NNAT may play a crucial role in synaptic and
possibly cognitive function.
The presence of ER throughout dendrites and synapses
provides a readily accessible Ca
2+ source, potentially allowing
NNAT to modulate local intracellular Ca
2+, and thus influence
site-specific events, such as LTP and LTD [21,63,64]. Since the
ER is continuous between the dendritic shaft and synapse,
transport along the ER membrane could facilitate the localization
of dendritically translated NNAT to the synapse. Thus, induction
of synaptic NNAT levels would not be limited exclusively to
translation at the synapse. Rather, such a mechanism would allow
dendritic protein synthesis to contribute to synaptic NNAT levels
as well [65,66].
TTX/APV-induced homeostatic plasticity regulates dendritic
translation by modulating the state of EF2 phosphorylation [51].
Our data here shows that synaptic Nnat mRNA translation is
indeed sensitive to EF2 phosphorylation; however, NNAT
induction was relatively modest, suggesting that other factors
may be involved. Retinoic acid has recently been implicated in
TTX/APV mediated homeostatic plasticity [11]. Molecularly,
RARa (retinoic acid receptor a) binds to consensus motifs in the
59UTR of certain mRNAs thus repressing their translation [67].
Unpublished data from our lab suggests that while RA does affect
NNAT protein levels, Nnat mRNA does not bind RARa ´, and is
probably not subject to direct translational regulation by RARa.
We are currently investigating additional molecular mechanisms
at play, including possible cis-acting motifs in the 59 and 39
untranslated regions that might underlie the translational control
or localization of Nnat mRNA. Our data also shows that TTX/
APV results in a transcription-dependent increase in NNAT.
Figure 3. Cell-wide NNAT protein levels are induced following TTX/APV treatment. (A) Immunofluorescent staining in cultured
hippocampal neurons using an antibody for NNAT (red), the 5.8S RNA antibody Y10b (green), and MAP2 (blue). Scale bar: 10 mm. (B) Magnified view
of boxed region in (A) showing localization of NNAT and Y10b signal. Grayscale used to enhance contrast. Arrowheads denote sites of NNAT and
ribosome co-localization. Scale bar: 1 mm. (C) NNAT is translationally regulated by TTX/APV as examined by immunoblot using lysates from
hippocampal cultures treated with TTX/APV for 8 hrs in the presence or absence of transcriptional or translational inhibitors. Actin was used as
loading control. (D) Quantification of total NNAT protein levels following treatment (expressed as fold change over no treatment (NT). Values were all
n=5 (3 independent experiments), where *** p,0.001, ** p,0.01, * p,0.05).
doi:10.1371/journal.pone.0024879.g003
NNAT Is a Dendritically Translated Ca
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previous reports have shown that TTX-induced homeostatic
plasticity can induce transcription via CaMKIV [68].
Many FMRP-regulated mRNAs are present in dendrites and it has
been proposed that their aberrant translation or mislocalization is an
underlying cause of Fragile X syndrome [69,70,71]. We observed
here that Nnat mRNA associates with FMRP, but likely through an
indirect interaction. Recently, Edbauer and colleagues reported that
a subset of microRNAs associate with FMRP to regulate synapse
structure and function [61]. Such an intermediate might also
participate in the FMRP-Nnat interaction. Interestingly, certain
hallmarks of the Fmr1
2/2 mouse (a model of Fragile X syndrome),
including enhanced mGluR-LTD, prolonged epileptiform bursts in
hippocampal CA3, and elongated dendritic spines are consistent with
the notion of perturbed Ca
2+ signaling [26,69,72]. We are currently
conducting studies inthe Fmr1
2/2mouse to investigate whetherthese
might also be linked to perturbed NNAT levels.
Using dendritic protein synthesis to regulate Ca
2+ signaling
presents an attractive mechanism as precise, spatial control of
Ca
2+ is essential for synapse formation, elimination and various
forms of learning-related plasticity [21]. NNAT is well-suited as
one such regulator as its local synthesis would allow for sustained
changes in cytoplasmic Ca
2+ levels. However, the precise
molecular events governing the interaction between NNAT and
the SERCA pump remains an important question to be answered.
That NNAT contains several putative sites of posttranslational
Figure 4. Neuronatin is dendritically translated in response to TTX/APV. (A) Cultured hippocampal neurons were immunostained for MAP2
and NNAT after no treatment, or treatment with 8 h TTX, 8 h TTX/APV, or TTX (8 h)+APV(1 h). Scale bar: 10 mm. (B) Magnified 30 mm straightened
dendritic segments taken from neurons treated as in (A) showing NNAT distribution. Images were grayscaled to enhance contrast. (C) Quantification
showing NNAT fluorescence in response to TTX/APV as a function of dendritic area (in mm
2). All values were compared to no treatment (NT). Sample
size: NT, n=39; 8 h APV, n=14; 8 h TTX/APV, n=30; ActD+8 h TTX/APV, n=30; aniso+TTX/APV, n=12; 8 h TTX alone, n=38; TTX (8 h)+APV (1 h),
n=18, TTX (8 h)+APV(1 h) ActD, n=22; TTX (8 h)+APV(1 h) aniso, n=27, actinomycin D (ActD), n=20, anisomycin (aniso), n=12. *** p,0.001). Each
condition was performed using at least 3 independent batches of cultures.
doi:10.1371/journal.pone.0024879.g004
NNAT Is a Dendritically Translated Ca
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ment of additional signaling pathways. Modification at such sites
could facilitate the integration of multiple signaling events at or
near the synapse, resulting in the tuning of intracellular Ca
2+
signals and any associated downstream pathways [73].
In summary, our data support that NNAT functions as a dendritic
Ca
2+ regulator whose levels are locally controlled in an activity-
dependent manner. Its potential involvement in cognitive disorders,
such as Fragile X syndrome, makes NNAT an appealing candidate
for future study. Interestingly, phenylketoneuria patients, some of
whom display autism-like symptoms, also exhibit abnormally high
levels of NNAT [74,75]. We posit therefore, that understanding the
action and regulation of NNAT may shed light on the molecular basis
of certain forms of cognitive impairment, particularly those associated
with aberrant Ca
2+ signaling. In a broader sense, our study also
underscores a relationship between local translation and Ca
2+
signaling, demonstrating the functional richness of dendritically
localized mRNAs and the pressing need for their characterization.
Materials and Methods
Antibodies
Information on antibodies can be found in the Supplementary
Information section.
Primers and constructs
Primer sequences and cloning strategies can be found in the
Supplementary Information section.
Animals
Sprague-Dawley rats used in these experiments were housed at
the Joint Science Department and handled according to guidelines
outlined and approved by the Institutional Animal Care and Use
Committee at the Joint Science Department of the Claremont
Colleges. Animals were euthanized using CO2 followed by
decapitation and tissue collection.
Calcium imaging
Calcium imaging was performed as described in Korkotian and
Segal [76,77]. Further details can be found in the Supplementary
Information section.
SERCA2 crosslinking and co-immunoprecipitation
Microsomes were prepared from P21 hippocampal tissue as
described previously [78]. For immunoprecipitation, SERCA2
antibody or rabbitIgG was prepared by prebinding with ProteinA/
G beads (Santa Cruz Biotechnology, Santa Cruz, CA) equilibrated
in NP-40 lysis buffer (1% Nonidet P-40 in PBS, pH 7.4) containing
protease inhibitor. DSP (dithiobis [succinimidylpropionate])(Pierce,
Rockford, IL) was dissolved in dry DMSO at 25 mM and used on
microsomes at 2 mM and incubated for 2 h on ice and quenched at
4uC overnight in 20 mM Tris, pH 7.5. Crosslinked microsomes
were pelleted at 140,0006ga t4 uC for 1 h. The supernatant was
removed and the microsomes resuspended in NP-40 lysis buffer
with protease inhibitor and lysed at 4uC overnight with agitation.
Lysates were precleared with Protein A/G beads, then incubated
with antibody-bound beads at 4uC overnight and samples prepared
Figure 5. NNAT translation in synaptoneurosomes is regulated by EF2 phosphorylation. (A) SNS were treated with anisomycin (aniso),
NH125 (an EF2 kinase inhibitor), 2 nM okadaic acid (OA) (an inhibitor of PP2A), or anisomycin+NH125, followed by immunoblot of phosphorylated
(pEF2) and total EF2. Values were graphed as a ratio of phospho- to total EF2 and normalized to no treatment (n=6 per group). (B) Total NNAT levels
in synaptoneurosomes treated as in (A). Values were normalized to actin and compared to the no treatment group. Sample size was n=7 (4
independent experiments) per group. ** p,0.01, * p,0.05).
doi:10.1371/journal.pone.0024879.g005
NNAT Is a Dendritically Translated Ca
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2+. (A) Neurons were transfected with the empty GFP vector (left) or the dual
expression GFP/NNATb (right), allowed to express for 8 hrs, and immunostained for NNAT (red) and GFP (green). Scale bar: 10 mm. (B) Left, neurons
transfected with empty vector or GFP/NNATb were loaded with Calcium Crimson-AM, and dendritic GFP and Calcium Crimson signals were acquired.
GFP/NNATb transfected cells were also treated with 40 mM glutamate (5 min) following Calcium Crimson loading to further induce Ca
2+ levels.
Calcium Crimson signal was grayscaled to enhance contrast. Values expressed as ratios of Calcium Crimson normalized to GFP fluorescence (empty
vector, n=12 dendrites, 4 neurons; GFP/NNATa ˆ, n=12 dendrites, 6 neurons; GFP/NNATb+Glu, n=10 dendrites, 5 neurons, **p,0.01, ***p,0.001).
Experiments were performed using 2 independent batches of cultures. (C) NNAT is localized to the endoplasmic reticulum (ER). Cultured neurons co-
immunostained with NNAT (red) and an ER marker against KDEL (green). Scale bar: 5 mm. (D) NNAT is 1.8-fold enriched in microsomes (ms) generated
from hippocampi compared to total protein. Microsome enrichment was assessed using antibodies against ER markers Grp94 (2.1-fold enrichment),
Grp78 (2.7-fold enrichment), and SERCA2 (3.0-fold enrichment).
doi:10.1371/journal.pone.0024879.g006
NNAT Is a Dendritically Translated Ca
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FMRP RNA co-immunoprecipitation
RNA co-immunoprecipitation was performed as described
previously [79] with the following exceptions: hippocampal tissue
was Dounce homogenized in RNAse-free lysis buffer containing
0.5% Nonidet P-40 in PBS, 300 mM NaCl, 2 mM MgCl2,2m M
CaCl2, 20 mM Tris, pH 7.4, 5 mM DTT, 1 mg/mL yeast tRNA,
protease inhibitors and 40 U/mL RNAseOut (Invitrogen, Carls-
bad, CA) and cleared by centrifugation. Antibody was prebound
to protein A/G beads in lysis buffer. Lysates were also precleared
using Protein A/G beads equilibrated in lysis buffer. The FMRP
antibody used for IP (Cell Signaling, Cat#4317) was against a
peptide spanning amino acids 536–593 of human origin, which is
similar to that used by others [80]. After overnight incubation with
lysates, antibody-bound beads were washed three times with lysis
buffer, then twice with lysis buffer containing 650 mM NaCl as
previously described [79]. RNA was extracted directly from beads
using Trizol (Invitrogen, Carlsbad, CA). Immunoprecipitation by
UV crosslinking was performed as described previously [67].
Microscopy
All images were taken using either a Zeiss Pascal LSM 510
confocal microscope and LSM software or a Nikon Eclipse 90i
epifluorescent microscope using Metamorph software (Universal
Imaging, Downington, PA).
Statistical Analysis
All statistics were performed using one-way analysis of variance
followed by post hoc analysis with a Newman-Keuls multiple
comparison test.
Figure 7. Neuronatin is associated with SERCA2 in the
hippocampus. (A) SERCA2 antibody immunoprecipitation efficiency
compared to rabbit IgG. 2.5% of input or immunoprecipitated samples
were loaded. (B) NNAT was co-immunoprecipitated from microsomes
using SERCA2 antibody. Pulldown was confirmed by immunoblotting
with SERCA2 or NNAT antibody. (C) Microsomes were crosslinked with
dithiobis [succinimidyl propionate] (DSP) followed by SERCA2 immu-
noprecipitation and immunoblot analysis. SERCA2 antibody (left)
recognizes a 114 kD band in uncrosslinked microsomes and a size-
shifted complex at 120–150 kD after crosslinking and IP. Right,
membrane was stripped and reprobed with NNAT antibody, revealing
the presence of NNAT within the 120–150 kD complex. (D) Overex-
pression of GFP/NNATb occludes Ca
2+ elevation by thapsigargin (GFP/
NNATb+thap), as measured using Calcium Crimson-AM, suggesting that
NNAT antagonizes SERCA pump activity (empty vector: n=24
dendrites, 14 neurons; GFP/NNATa ˆ: n=33 dendrites, 14 neurons; empty
Figure 8. Nnat mRNA associates with FMRP. (A)R N Ac o -
immunoprecipitation (non-UV crosslinked) followed by RT-PCR using
FMRP antibody or rabbit IgG for Nnat mRNA. Known FMRP binding
targets, Arc and Fmr1, are enriched in the FMRP immunoprecipitated
sample, whereas Gapdh, a non-target, is not. Based on product size,
Nnatb was the predominant FMRP-binding isoform. RT-PCR using total
hippocampal RNA is shown in the left column. (B) FMRP immunopre-
cipitation efficiency was tested using 2.5% input or immunoprecipitat-
ed hippocampal protein, probed with FMRP antibody and compared to
rabbit IgG or no antibody.
doi:10.1371/journal.pone.0024879.g008
vector+thap: 18 dendrites, 8 neurons; GFP/NNATb+thap: 19 dendrites, 8
neurons; GFP/NNATb+thap+Glu: 19 dendrites, 9 neurons. **p,0.01,
*p,0.05). Experiments were performed using at least 2 independent
batches of cultures.
doi:10.1371/journal.pone.0024879.g007
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Supporting Information
Figure S1 (A) NNAT expression extends into distal dendrites in
hippocampal slice. Top left, 406merged image from Figure 2B,
MAP2 (green), NNAT (red). Top right, magnified image (in order
to highlight NNAT expression .100 mm from the soma
(arrowhead). Asterisk denotes a possible interneuron in the
dendritic layer. Scale bar: 10 mm. (B) NNAT antibody is specific
for NNAT by immunocytochemistry. HeLa cells were transfected
with NNATb or empty vector (pCI-Neo), then immunostained
using the NNAT antibody (green). Cells were counterstained with
propidium iodide (red). Scale bar: 50 mm. (C) left, Western blot for
NNAT and right, RT-PCR for Nnat mRNA using P21 and adult (7
month old) rat hippocampal tissue showing both a and b isoforms.
(TIF)
Figure S2 (A) Sense control for Nnat fluorescent in situ
hybridization. Top left panel, Nnat sense control (green), top right
panel, NNAT immunofluorescence (red), bottom left, MAP2 (blue),
bottom right, merge. Scale bar: 10 mm. (B) Synaptoneurosome
enrichment was assessed by Western blot using antibodies against
Histone 3 (cell body marker) or PSD-95 (synaptic marker) on equal
amounts of total or synaptoneurosome (SNS) protein samples.
SERCA2 is also present in SNS.
(TIF)
Figure S3 TTX/APV-induced local NNAT synthesis is inhib-
ited by the translation inhibitor, cycloheximide. Quantification
summarizing NNAT fluorescence as a function of dendritic area
(in mm
2) in response to TTX/APV treatment in the presence or
absence of cycloheximide. All values were compared to no
treatment (NT) using one-way ANOVA followed by Newman-
Keuls multiple comparison test (sample size: NT, n=34 dendrites;
8 h TTX/APV, n=39 dendrites; actinomycin D (ActD), n=35
dendrites; ActD+8 h TTX/APV, n=33 dendrites; cycloheximide
(CHX), n=11 dendrites; CHX+TTX/APV, n=13 dendrites, ***
p,0.001). Experiments were performed using at least 3 batches of
independent cultures.
(TIF)
Methods S1
(DOCX)
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